Brief: Anika Reports Q4 Adjusted Loss Per Share $0.23

Anika Therapeutics

08/03/2022 23:06

March 8 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS FOURTH QUARTER AND YEAR-END 2021 FINANCIAL
RESULTS
    * Q4 ADJUSTED LOSS PER SHARE $0.23
    * Q4 LOSS PER SHARE $0.40
    * Q4 REVENUE ROSE 10 PERCENT TO $35.8 MILLION
    * EXPECTS ITS OVERALL REVENUE FOR FISCAL YEAR 2022 TO BE UP
LOW TO
MID-SINGLE DIGIT PERCENT COMPARED WITH 2021
    * Q4 EARNINGS PER SHARE VIEW $-0.25, REVENUE VIEW $32.1
MILLION --
REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $163.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX37kpBN 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))